Alderman E, Ananthakrishnan A, Barth B, et al. Respiratory syncytial virus infection. ClinicalKey. https://www.clinicalkey.com/. 24 Sep 2024.
Alfano F, Bigoni T, Caggiano FP, et al. Respiratory syncytial virus infection in older adults: an update. Drugs Aging. 2024 Jun;41(6):487-505. doi: 10.1007/s40266-024-01118-9. Accessed 21 Nov 2024. PMID: 38713299
Australian Government. Australian immunization handbook. Australian Government. https://immunisationhandbook.health.gov.au/. 09 Oct 2024.
Barr F, Graham B. Respiratory syncytial virus infection: clinical features and diagnosis in infants and children. UpToDate. https://www.uptodate.com/. 10 Sep 2024.
Barr F, Graham B. Respiratory syncytial virus infection: prevention in infants and children. UpToDate. https://www.uptodate.com/. 26 Aug 2024.
Barr F, Graham B. Respiratory syncytial virus infection: treatment in infants and children. UpToDate. https://www.uptodate.com/. 25 Nov 2024.
Centers for Disease Control and Prevention (CDC). Adult immunization schedule notes. CDC. https://www.cdc.gov/. 06 Dec 2023.
Centers for Disease Control and Prevention (CDC). Clinical overview of RSV. CDC. https://www.cdc.gov/. 30 Aug 2024.
Gatt D, Martin I, Al Fouzan R, et al. Prevention and treatment strategies for respiratory syncytial virus (RSV). Pathogens. 2023 Jan;12(2):154. doi: 10.3390/pathogens12020154. PMID: 36839426
Ison M, Nam H. Respiratory syncytial virus infection in adults. UpToDate. https://www.uptodate.com/. 15 Oct 2024. Accessed 21 Nov 2024.
Jones JM, Fleming-Dutra KE, Prill MM, et al. Use of Nirsevimab for the prevention syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Aug;72(34):920-925. doi: 10.15585/mmwr.mm7234a4. PMID: 37616235
National Health Service (NHS). Respiratory syncytial virus (RSV). NHS. https://www.nhs.uk/. 05 Jul 2024. Accessed 21 Nov 2024.
